Cargando…
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis and represents a major public health issue, as both its incidence and mortality are expecting to increase steeply over the next years. Effective screening strategies are lacking, and most patients are diagnosed with unresectable...
Autores principales: | Casolino, Raffaella, Corbo, Vincenzo, Beer, Philip, Hwang, Chang-il, Paiella, Salvatore, Silvestri, Valentina, Ottini, Laura, Biankin, Andrew V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265115/ https://www.ncbi.nlm.nih.gov/pubmed/35805011 http://dx.doi.org/10.3390/cancers14133239 |
Ejemplares similares
-
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis
por: Casolino, Raffaella, et al.
Publicado: (2021) -
Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake
por: Golan, Talia, et al.
Publicado: (2023) -
Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward
por: Casolino, Raffaella, et al.
Publicado: (2021) -
A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing
por: Paiella, S., et al.
Publicado: (2023) -
Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021)